论文部分内容阅读
目的对急性心肌梗死8例治疗临床观察进行探讨。方法选择2012年01月～2012年08月在本院就诊的急性心肌梗死患者8例,除予以常规治疗外,还采用尿激酶溶栓治疗。结果 24h内即明确诊断者5例(96.15%),就诊后2～4d内明确诊断者3例(3.85%)。结论尿激酶是我国目前应用最广的溶栓剂,符合我国卫生国情,尤其基层值得推广。
Objective To investigate the clinical observation of 8 cases of acute myocardial infarction. Methods Eight patients with acute myocardial infarction from January 2012 to August 2012 in our hospital were treated with urokinase thrombolysis in addition to routine treatment. Results Within 24 hours, 5 cases (96.15%) were confirmed and 3 cases (3.85%) were diagnosed within 2 ~ 4 days after treatment. Conclusions Urokinase is currently the most widely used thrombolytic agent in our country, which is in line with China’s national health conditions. In particular, it is worth to promote grassroots.